moxalactam has been researched along with Bacteroides Infections in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (88.89) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Date, H; Goi, H; Hara, T; Ishii, T; Jinzaki, M; Kasai, T; Matsugami, A; Miyauchi, K; Shindo, H; Watanabe, T | 1 |
| Danielsson, D; Schwan, A | 1 |
| Gootz, TD; Martin, RR; Moellering, RC; Perkins, RL; Sanders, CC; Sanders, WE; Strike, DG | 1 |
| Arensman, JB; Harris, RW; Moore, WL; Rissing, JP | 1 |
| Chandrasekar, PH; Chokkavelu, V; Kannangara, DW; Le Frock, JL; Rolston, KV | 1 |
| Bourquelot, P; Bouscary, D; Dreyfus, F; Paul, G; Picard, F; Tulliez, M; Varet, B | 1 |
| Danziger, LH; Ferron, JL; Gauderer, MW; Gordon, N; Hau, T; Stellato, TA | 1 |
| Barza, M; Gorbach, SL; Ho, JL; Kellum, JM; O'Donnell, TF; Tally, FP | 1 |
| Frommelt, L; Teichmann, W; Wittmann, DH | 1 |
1 review(s) available for moxalactam and Bacteroides Infections
| Article | Year |
|---|---|
Moxalactam vs tobramycin-clindamycin. A randomized trial in secondary peritonitis.
Topics: Abscess; Adolescent; Adult; Bacteroides Infections; Clindamycin; Clinical Trials as Topic; Combined Modality Therapy; Drug Therapy, Combination; Escherichia coli Infections; Humans; Hypoprothrombinemias; Infant, Newborn; Middle Aged; Moxalactam; Peritonitis; Premedication; Prospective Studies; Random Allocation; Sepsis; Streptococcal Infections; Surgical Wound Infection; Tobramycin | 1988 |
2 trial(s) available for moxalactam and Bacteroides Infections
| Article | Year |
|---|---|
Moxalactam vs tobramycin-clindamycin. A randomized trial in secondary peritonitis.
Topics: Abscess; Adolescent; Adult; Bacteroides Infections; Clindamycin; Clinical Trials as Topic; Combined Modality Therapy; Drug Therapy, Combination; Escherichia coli Infections; Humans; Hypoprothrombinemias; Infant, Newborn; Middle Aged; Moxalactam; Peritonitis; Premedication; Prospective Studies; Random Allocation; Sepsis; Streptococcal Infections; Surgical Wound Infection; Tobramycin | 1988 |
Randomized prospective study comparing moxalactam and cefoxitin with or without tobramycin for the treatment of serious surgical infections.
Topics: Adolescent; Adult; Aged; Bacterial Infections; Bacteroides fragilis; Bacteroides Infections; Cefoxitin; Drug Therapy, Combination; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Moxalactam; Prospective Studies; Random Allocation; Surgical Wound Infection; Tobramycin | 1986 |
7 other study(ies) available for moxalactam and Bacteroides Infections
| Article | Year |
|---|---|
[Antibacterial activity of MT-141 against anaerobic bacteria].
Topics: Animals; Bacteria, Anaerobic; Bacteroides fragilis; Bacteroides Infections; Cefmetazole; Cephamycins; Clostridium Infections; Clostridium perfringens; Drug Resistance, Microbial; Mice; Moxalactam | 1984 |
Immune response to Bacteroides fragilis in experimentally infected rabbits.
Topics: Animals; Bacteroides fragilis; Bacteroides Infections; Cephamycins; Fluorescent Antibody Technique; Histocompatibility Antigens Class II; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Moxalactam; Rabbits; Suppuration | 1983 |
Resistance to cefamandole: a collaborative study of emerging clinical problems.
Topics: Adult; Aged; Bacteroides Infections; beta-Lactamases; Cefamandole; Cefotaxime; Cefoxitin; Cephalosporins; Cephamycins; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Humans; Isoelectric Focusing; Male; Middle Aged; Moxalactam; Penicillin Resistance; Penicillins | 1982 |
Antimicrobial activity of latamoxef (moxalactam) against both Bacteroides fragilis and Escherichia coli in an intraperitoneal abscess model.
Topics: Abscess; Animals; Ascitic Fluid; Bacteroides fragilis; Bacteroides Infections; Escherichia coli Infections; Moxalactam; Peritoneal Diseases; Rabbits | 1984 |
Comparative efficacy of four antibiotics in anaerobic pulmonary infection. An experimental model in rabbits.
Topics: Animals; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacteroides fragilis; Bacteroides Infections; Cefoxitin; Eubacterium; Fusobacterium Infections; Male; Metronidazole; Mezlocillin; Microbial Sensitivity Tests; Moxalactam; Peptococcus; Pneumonia; Rabbits | 1984 |
Hemophagocytic syndrome associated with Bacteroides fragilis infection in a patient with acute monoblastic leukemia.
Topics: Amikacin; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Bacteroides fragilis; Bacteroides Infections; Ceftazidime; Cytarabine; Daunorubicin; Drug Therapy, Combination; Fatal Outcome; Female; Histiocytosis, Non-Langerhans-Cell; Humans; Leukemia, Monocytic, Acute; Middle Aged; Moxalactam; Tonsillitis; Vancomycin | 1996 |
[Significance of the causative agent of infection for therapy of purulent peritonitis].
Topics: Abscess; Anti-Bacterial Agents; Bacterial Infections; Bacteroides Infections; Clostridium Infections; Drug Therapy, Combination; Escherichia coli Infections; Female; Humans; Middle Aged; Moxalactam; Peritonitis | 1985 |